NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 239 filers reported holding NEKTAR THERAPEUTICS in Q2 2021. The put-call ratio across all filers is 0.96 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $1,113 | -98.9% | 492,500 | +1486.2% | 0.02% | +1500.0% |
| Q3 2022 | $99,000 | -95.6% | 31,049 | -92.5% | 0.00% | -96.4% |
| Q1 2022 | $2,241,000 | +694.7% | 415,709 | +1890.6% | 0.03% | +833.3% |
| Q4 2021 | $282,000 | -72.3% | 20,884 | -63.2% | 0.00% | -78.6% |
| Q3 2021 | $1,019,000 | +38.3% | 56,756 | +32.1% | 0.01% | +75.0% |
| Q2 2021 | $737,000 | +162.3% | 42,964 | +159.7% | 0.01% | +166.7% |
| Q4 2020 | $281,000 | -66.5% | 16,544 | -67.2% | 0.00% | -82.4% |
| Q3 2020 | $838,000 | +1.7% | 50,503 | +42.0% | 0.02% | -19.0% |
| Q2 2020 | $824,000 | -7.5% | 35,558 | -13.9% | 0.02% | +23.5% |
| Q4 2019 | $891,000 | – | 41,279 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Cormorant Asset Management, LP | 1,828,400 | $89,281,000 | 6.61% |
| Cormorant Asset Management, LP | 1,500,000 | $73,245,000 | 5.42% |
| Camber Capital Management LP | 2,000,000 | $97,660,000 | 3.76% |
| Rhenman & Partners Asset Management AB | 617,652 | $30,160,000 | 3.09% |
| BRIDGER MANAGEMENT, LLC | 1,134,414 | $55,393,000 | 3.00% |
| First Light Asset Management, LLC | 374,251 | $18,275,000 | 2.84% |
| Gs Investments, Inc. | 54,000 | $2,636,820,000 | 1.97% |
| SABBY MANAGEMENT, LLC | 241,922 | $11,813,000 | 1.82% |
| QUANTRES ASSET MANAGEMENT Ltd | 50,000 | $2,441,000 | 1.41% |
| Tibra Equities Europe Ltd | 173,183 | $8,457,000 | 1.27% |